X-Tream quality assurance in synchrotron X-ray microbeam radiation therapy
- 26 July 2016
- journal article
- research article
- Published by International Union of Crystallography (IUCr) in Journal of Synchrotron Radiation
- Vol. 23 (5) , 1180-1190
Abstract
Microbeam radiation therapy (MRT) is a novel irradiation technique for brain tumours treatment currently under development at the European Synchrotron Radiation Facility in Grenoble, France. The technique is based on the spatial fractionation of a highly brilliant synchrotron X-ray beam into an array of microbeams using a multi-slit collimator (MSC). After promising pre-clinical results, veterinary trials have recently commenced requiring the need for dedicated quality assurance (QA) procedures. The quality of MRT treatment demands reproducible and precise spatial fractionation of the incoming synchrotron beam. The intensity profile of the microbeams must also be quickly and quantitatively characterized prior to each treatment for comparison with that used for input to the dose-planning calculations. The Centre for Medical Radiation Physics (University of Wollongong, Australia) has developed an X-ray treatment monitoring system (X-Tream) which incorporates a high-spatial-resolution silicon strip detector (SSD) specifically designed for MRT. In-air measurements of the horizontal profile of the intrinsic microbeam X-ray field in order to determine the relative intensity of each microbeam are presented, and the alignment of the MSC is also assessed. The results show that the SSD is able to resolve individual microbeams which therefore provides invaluable QA of the horizontal field size and microbeam number and shape. They also demonstrate that the SSD used in the X-Tream system is very sensitive to any small misalignment of the MSC. In order to allow as rapid QA as possible, a fast alignment procedure of the SSD based on X-ray imaging with a low-intensity low-energy beam has been developed and is presented in this publication.Keywords
This publication has 42 references indexed in Scilit:
- Effects of microbeam radiation therapy on normal and tumoral blood vesselsPhysica Medica, 2015
- Medical physics aspects of the synchrotron radiation therapies: Microbeam radiation therapy (MRT) and synchrotron stereotactic radiotherapy (SSRT)Physica Medica, 2015
- Identification of AREG and PLK1 pathway modulation as a potential key of the response of intracranial 9L tumor to microbeam radiation therapyInternational Journal of Cancer, 2014
- A two dimensional silicon detectors array for quality assurance in stereotactic radiotherapy: MagicPlate‐512Medical Physics, 2014
- Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brainRadiotherapy and Oncology, 2013
- Chalcone JAI-51 improves efficacy of synchrotron microbeam radiation therapy of brain tumorsJournal of Synchrotron Radiation, 2012
- Evaluation of a 2D detector array for patient-specific VMAT QA with different setupsPhysics in Medicine & Biology, 2011
- Preferential Effect of Synchrotron Microbeam Radiation Therapy on Intracerebral 9L Gliosarcoma Vascular NetworksInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapiesPhysics in Medicine & Biology, 2010
- MOSFET dosimetry for microbeam radiation therapy at the European Synchrotron Radiation FacilityMedical Physics, 2003